North America Health Economics Outcomes Research (HEOR) Services Market By Service Type(Economic Modelling, Health Outcomes Assessment, Real-World Evidence Generation, Health Technology Assessment (HTA) Support, Market Access Consulting, and Others), By Service Providers (Consulting Firms, Contract Research Organizations (CROs), and Others), By End User(Pharmaceutical Companies, Biotechnology Firms, Medical Device Manufacturers, Healthcare Providers, and Others), North American Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. North America Health Economics Outcomes Research Services Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Shift towards value-based healthcare models emphasizes the importance of cost-effectiveness analyses.

3.2.2. Innovations in data analytics and modeling enhance the quality of HEOR studies.

3.2.3. Growing demand from regulatory bodies for economic evidence to support drug approval processes.

3.3. Key industry pitfalls & challenges

3.3.1. Difficulty in integrating diverse data sources for comprehensive analyses.

3.3.2. Limited budgets for healthcare providers may reduce spending on HEOR services.

3.3.3. Insufficient availability of qualified HEOR experts can restrict service delivery.

3.4. Market Opportunities

3.4.1. Utilizing AI for predictive modelling and data analysis can improve efficiency and accuracy.

3.4.2. Increasing focus on sustainable healthcare practices may drive demand for HEOR analyses that evaluate environmental impacts.

3.4.3. Assessing the economic impact of digital health tools can create niche markets within HEOR.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. North America Health Economics Outcomes Research Services Market, Service Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Service Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Economic Modelling

4.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)

4.3. Health Outcomes Assessment

4.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)

4.4. Real-World Evidence Generation

4.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)

4.5. Health Technology Assessment (HTA) Support

4.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)

4.6. Market Access Consulting

4.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)

4.7. Others

4.7.1. Market Size and Forecast, By 2025-2035 (USD Billion)

5. North America Health Economics Outcomes Research Services Market, Service Providers Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Service Providers, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Consulting Firms

5.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)

5.3. Contract Research Organizations (CROs)

5.3.1. Market Size and Forecast, By 2025-2035 (USD Billion)

5.4. Others

5.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)

6. North America Health Economics Outcomes Research Services Market, End User Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By End User, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Pharmaceutical Companies

6.2.1. Market Size and Forecast, By 2025-2035 (USD Billion)

6.3. Biotechnology Firms

6.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

6.4. Medical Device Manufacturers

6.4.1. Market Size and Forecast, By 2025-2035 (USD Billion)

6.5. Healthcare Providers

6.5.1. Market Size and Forecast, By 2025-2035 (USD Billion)

6.6. Others

6.6.1. Market Size and Forecast, By 2025-2035 (USD Billion)

7. North America Health Economics Outcomes Research Services Market, Region Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Region, 2025 & 2035

7.1.2. Market Revenue, By Region, 2025-2035 (USD Billion)

7.2. North America

7.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

7.2.2. North America Market Revenue, By Service Type, 2025-2035

7.2.3. North America Market Revenue, By Service Providers, 2025-2035

7.2.4. North America Market Revenue, By End User, 2025-2035

7.2.5. The U.S.

7.2.5.1. U.S. Market Revenue, By Service Type, 2025-2035

7.2.5.2. U.S. Market Revenue, By Service Providers, 2025-2035

7.2.5.3. U.S. Market Revenue, By End User, 2025-2035

7.2.6. Canada

7.2.6.1. Canada Market Revenue, By Service Type, 2025-2035

7.2.6.2. Canada Market Revenue, By Service Providers, 2025-2035

7.2.6.3. Canada Market Revenue, By End User, 2025-2035

8. Company Profile

8.1. Mediant Health Resources

8.1.1. Business Overview

8.1.2. Financial Performance

8.1.3. Service/Service Offerings

8.1.4. Strategies & recent developments

8.1.5. SWOT Analysis

8.2. Truist Advisory Services

8.2.1. Business Overview

8.2.2. Financial Performance

8.2.3. Service/Service Offerings

8.2.4. Strategies & recent developments

8.2.5. SWOT Analysis

8.3. Analysis Group

8.3.1. Business Overview

8.3.2. Financial Performance

8.3.3. Service/Service Offerings

8.3.4. Strategies & recent developments

8.3.5. SWOT Analysis

8.4. Zynx Health

8.4.1. Business Overview

8.4.2. Financial Performance

8.4.3. Service/Service Offerings

8.4.4. Strategies & recent developments

8.4.5. SWOT Analysis

8.5. The Kinetix Group

8.5.1. Business Overview

8.5.2. Financial Performance

8.5.3. Service/Service Offerings

8.5.4. Strategies & recent developments

8.5.5. SWOT Analysis

8.6. Pharmerit International

8.6.1. Business Overview

8.6.2. Financial Performance

8.6.3. Service/Service Offerings

8.6.4. Strategies & recent developments

8.6.5. SWOT Analysis

8.7. Kantar Health

8.7.1. Business Overview

8.7.2. Financial Performance

8.7.3. Service/Service Offerings

8.7.4. Strategies & recent developments

8.7.5. SWOT Analysis

8.8. Boston Healthcare

8.8.1. Business Overview

8.8.2. Financial Performance

8.8.3. Service/Service Offerings

8.8.4. Strategies & recent developments

8.8.5. SWOT Analysis

8.9. Bain & Company

8.9.1. Business Overview

8.9.2. Financial Performance

8.9.3. Service/Service Offerings

8.9.4. Strategies & recent developments

8.9.5. SWOT Analysis

8.10. Deloitte Consulting

8.10.1. Business Overview

8.10.2. Financial Performance

8.10.3. Service/Service Offerings

8.10.4. Strategies & recent developments

8.10.5. SWOT Analysis

8.11. The Health Economics Group

8.11.1. Business Overview

8.11.2. Financial Performance

8.11.3. Service/Service Offerings

8.11.4. Strategies & recent developments

8.11.5. SWOT Analysis

8.12. Clarion Healthcare

8.12.1. Business Overview

8.12.2. Financial Performance

8.12.3. Service/Service Offerings

8.12.4. Strategies & recent developments

8.12.5. SWOT Analysis

8.13. Health Strategies Group

8.13.1. Business Overview

8.13.2. Financial Performance

8.13.3. Service/Service Offerings

8.13.4. Strategies & recent developments

8.13.5. SWOT Analysis

8.14. Huron Consulting Group

8.14.1. Business Overview

8.14.2. Financial Performance

8.14.3. Service/Service Offerings

8.14.4. Strategies & recent developments

8.14.5. SWOT Analysis

8.15. Milliman

8.15.1. Business Overview

8.15.2. Financial Performance

8.15.3. Service/Service Offerings

8.15.4. Strategies & recent developments

8.15.5. SWOT Analysis

8.16. Avalere Health

8.16.1. Business Overview

8.16.2. Financial Performance

8.16.3. Service/Service Offerings

8.16.4. Strategies & recent developments

8.16.5. SWOT Analysis